CellWell record HH-104481
Efficacy and Safety of Vitamin E in Adults With Metabolic Dysfunction-Associated Steatohepatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Helai Hussaini; Manpreet Kaur Dhanjal; Rahman Hameed Mohammed Abdul; Olaniyi Fadeyi; Najeeha A Bhatti; Mohammed Qasim Rauf; Calvin R Wei; Adil Amin
2025
In plain language
A meta-analysis of three randomized trials in adults with metabolic dysfunction-associated steatohepatitis found vitamin E (300 to 800 mg/day) lowered liver enzymes and improved fibrosis, though overall disease resolution was not significantly different from placebo.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-104481
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.